Clinical trial
Ergogenic Effect of PDE-5 Inhibitors at Moderate Altitude
NCT03710369 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ergogenic Effect of PDE-5 Inhibitors at Moderate Altitude
- Lead sponsor
- University of British Columbia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2015
- Completion date
- October 2, 2018
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
altitude, exercise, hypoxia, sildenafil